KW-8232 is an orally bioavailable small molecule developed for osteoporosis research. It functions by inhibiting the biosynthesis of prostaglandin E2 (PGE2). This mechanism has been investigated in both in vitro assays and in vivo animal models for bone metabolism studies.
Molecular Weight:
705.27
CAS Number:
[217813-15-5]
Formula:
C37H41ClN4O6S
Target:
Others,Prostaglandin Receptor,SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted